LOS ANGELES, CA--(Marketwire - Jul 26, 2012) - MMRGlobal, Inc. (
According to Bob Lorsch, MMRGlobal CEO, "MMRGlobal's visit through the Asia Pacific region will give us an opportunity to personally present our Personal Health Record products and services to government and private business and industry on a one-on-one basis and to explain the benefits of incorporating our patented MyMedicalRecords services into their eHealth plans for the future."
MMR also announced plans to establish a greater overseas presence in the UK headed up by Executive Vice President Richard M. Lagani. Mr. Lagani will manage the launch of several new Chartis/AIG International programs and oversee sales of the Company's MMRPro professional systems and PHRs to hospitals and other healthcare providers.
The Company has been expanding overseas over the past several years starting with the launch of its Unis Tonghe MMR International Health Management Service Co., Ltd., Joint Venture in China. This was followed by the signing of license agreements in Australia and currently the integration of its PHR services at St. Helen's Hospital in the United Kingdom.
About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.
Forward-Looking Statements
Statements in this press release that are not strictly historical in nature, including future performance, expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMRGlobal, Inc.'s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, changes in Australia's eHealth system; as it builds and develops; the risk our products and services are not adopted or viewed favorably by consumers and the healthcare community, both in the U.S. and internationally; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry, both in the U.S. and internationally; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing, exploiting and defending our intellectual property rights including those pertaining to our biotechnology assets; litigation matters; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the United States Securities and Exchange Commission. MMRGlobal, Inc. is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
Contact Information:
CONTACT:
MMRGlobal Contact
Michael Selsman
Public Communications Co.
(310) 922-7033
ms@publiccommunications.biz